Vägen till en statlig finansieringsmodell av särläkemedel
On Wednesday 24 June, we organise Life Science-dagen in a large tent at Hamnplan, in collaboration with AbbVie, AstraZeneca, Chiesi, Lund University, Novo Nordisk, Roche and SmiLe Venture Hub.
At 09:00-09:45, there will be a seminar in Swedish on ”Vägen till en statlig finansieringsmodell av särläkemedel”, hosted by AstraZeneca. Please note that the program and its speakers/panelists might be updated before it takes place – updated program in the official program for Almedalsveckan.
Seminar focus
Rare Diseases and Orphan Drugs – How Do We Create Equal Access to Orphan Medicines Across the Country?
Presentation of a new report on the cost of medicines for rare diseases (orphan drugs) in Sweden, followed by a panel discussion on how the state can fund these medicines and how this could provide equal access for people across the country. The panel includes representatives from the Swedish National Organisation for Rare Diseases, regional politicians, experts from healthcare and government agencies, as well as Alexion.
Life Science-dagen aims to establish a high-profile, unified forum and meeting point dedicated to life science at Almedalsveckan, in line with our role as the largest life science park in Scandinavia.
During Almedalsveckan 2026 Medicon Village also organise Skånes Innovationsarena on Thursday 25 June.
For more information on Life Science-dagen, please contact mikael.lagerwall@mediconvillage.se.
Information
- When: to
- Where: Hamnplan, plats 200, Visby
- Organizer: AstraZeneca
- Language: Swedish
Contact information
- Elin Fernholm
- elin.fernholm1@astrazeneca.com
- https://www.astrazeneca.se/